Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load
Background & Aims: Liver steatosis may occur concomitantly in patients with chronic hepatitis B infection (CHB) and is implicated in increased morbidity and mortality. Hepatitis B virus (HBV) viral load is a marker for disease progression and long-term outcomes in CHB. We investigated the associ...
Main Authors: | Noam Peleg, Assaf Issachar, Orly Sneh Arbib, Michal Cohen-Naftaly, Marius Braun, Moshe Leshno, Alon Barsheshet, Amir Shlomai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-05-01
|
Series: | JHEP Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555919300096 |
Similar Items
-
A decision-making model for prediction of a stable disease course in chronic hepatitis B patients
by: Imri Ofri, et al.
Published: (2023-12-01) -
Cabozantinib for patients with advanced hepatocellular carcinoma: a cost-effectiveness analysis
by: Amir Shlomai, et al.
Published: (2019-09-01) -
Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control
by: Alessandro Ciresi, et al.
Published: (2018-01-01) -
Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical Trial
by: Yuval Ishay, et al.
Published: (2024-01-01) -
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
by: Assaf Moore, et al.
Published: (2017-10-01)